|
Follow up (months)
|
60 ± 21
|
60 ± 21
|
63 ± 19
|
0.569
|
|
Age (years)
|
53 ± 10
|
53 ± 9
|
52 ± 11
|
0.661
|
|
Patients < 65 years old
|
80 (87 %)
|
69 (89 %)
|
11 (85 %)
|
0.694
|
|
Patients 65–74 years old
|
10 (11 %)
|
8 (10 %)
|
2 (15 %)
|
0.631
|
|
Patients > 65–74 years old
|
1 (1 %)
|
1 (1 %)
|
0 (0 %)
|
1.000
|
|
Female gender
|
21 (23 %)
|
19 (24 %)
|
2 (15 %)
|
0.726
|
|
LV dysfunction
|
11 (12 %)
|
8 (10 %)
|
3 (23 %)
|
0.189
|
|
Hypertension
|
73 (80 %)
|
62 (80 %)
|
11 (85 %)
|
1.000
|
|
Diabetes Mellitus
|
5 (6 %)
|
4 (5 %)
|
1 (8 %)
|
0.546
|
|
History of TIA
|
5 (5 %)
|
4 (8 %)
|
1 (8 %)
|
1.000
|
|
Stroke on adequate anticoagulation
|
2 (2 %)
|
2 (2 %)
|
0 (0 %)
|
1.000
|
|
Peripheral vascular disease
|
4 (4 %)
|
4 (5 %)
|
0 (0 %)
|
1.000
|
|
CHA2DS2-VASc Score = 0
|
9 (10 %)
|
8 (10 %)
|
1 (8 %)
|
0.774
|
|
CHA2DS2-VASc Score = 1
|
47 (52 %)
|
40 (51 %)
|
7 (54 %)
|
0.864
|
|
CHA2DS2-VASc Score ≥2
|
35 (38 %)
|
30 (38 %)
|
4 (30 %)
|
0.596
|
|
AF duration (months)
|
73 ± 66
|
40 ± 37
|
79 ± 69
|
0.006
|
|
Failed catheter ablation
|
10 (21 %)
|
17 (22 %)
|
2 (15 %)
|
0.598
|
|
Failed catheter ablation >1 time
|
9 (10 %)
|
7 (10 %)
|
2 (15 %)
|
0.474
|
|
Median LVEF (%)
|
55 (30–65)
|
55 (30–65)
|
55 (40–55)
|
0.293
|
|
LA diameter (cm)
|
4.3 ± 0.5
|
4.2 ± 0.5
|
4.7 ± 0.4
|
0.046
|
|
Operative
|
|
Median operation duration (min)
|
180 (90–280)
|
180 (90–280)
|
170 (120–240)
|
0.497
|
|
Ablation time (min)
|
14 ± 4
|
13 ± 4
|
15 ± 6
|
0.772
|
|
PV Ablation time (min)
|
10 ± 3
|
10 ± 3
|
10 ± 5
|
0.864
|
|
RA Ablation time (min)
|
5 ± 3
|
6 ± 4
|
4 ± 2
|
0.293
|
|
Division of ligament of Marshall
|
61 (67 %)
|
55 (71 %)
|
6 (46 %)
|
0.112
|
|
Box lesion around PVs (exit block achieved)
|
80 (88 %)
|
70 (90 %)
|
10 (77 %)
|
0.189
|
